Viking Therapeutics Inc. (VKNG) saw a surge in its stock price following the release of positive results from its Phase 1 clinical trial for its oral obesity drug.
Merck, a global pharmaceutical giant, has announced its plans to acquire Harpoon Therapeutics, a biotechnology company specializing in the development of immunotherapies. This strategic move aims to further diversify Merck’s oncology pipeline and strengthen its position in the highly competitive field of cancer treatment.
Novo Nordisk, a leading global healthcare company, has recently announced its strategic research collaborations with Omega Therapeutics and Cellarity. These partnerships aim to develop innovative treatment approaches for cardiometabolic diseases, including cardiovascular disease and metabolic disorders such as diabetes.
